Market Place
Sourcing Support
MeiraGTx`s gene therapy improves motor function in Ph 2 trial
16 Oct 2024 //
FIERCEBIOTECH
MeiraGTx Holdings Climbs On Asset Purchase Agreement With Janssen Pharma
22 Dec 2023 //
NASDAQ
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
31 Oct 2023 //
FIERCE BIOTECH
MeiraGTx gene therapy for ALS rescues deficits in rodents
30 Oct 2023 //
FIERCE BIOTECH
Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of Invg Gene Therapy
03 Oct 2022 //
PRESS RELEASE
MeiraGTx shows off gene therapy manufacturing site in Ireland
19 Sep 2022 //
FIERCEPHARMA
MeiraGTx Announces Positive Prelim Data from the AQUAx Phase 1 Clinical Trial
07 Dec 2021 //
GLOBENEWSWIRE
MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA
26 Jan 2021 //
GLOBENEWSWIRE
J&J buys an early-stage gene therapy for the eye — the only known program
03 Dec 2020 //
ENDPTS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.